Archives
MTT: Gold-Standard Tetrazolium Salt for In Vitro Cell Via...
MTT: Gold-Standard Tetrazolium Salt for In Vitro Cell Viability and Metabolic Activity Assays
Executive Summary: MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) is a cationic tetrazolium salt widely used for colorimetric cell viability assays in biomedical research (APExBIO B7777). Its reduction to insoluble purple formazan by NADH-dependent oxidoreductases in viable cells provides a quantitative readout of metabolic activity and proliferation (Zhang et al., 2020). MTT is membrane-permeable, highly soluble in DMSO, ethanol, and (with ultrasonic assistance) water, and is stable when stored at -20°C. Its sensitivity and reproducibility position it as the benchmark for in vitro cell viability, apoptosis, and metabolic activity measurement (internal reference).
Biological Rationale
Cell viability and metabolic activity are core metrics in cancer, apoptosis, and toxicity research. MTT is specifically designed to provide a direct, quantitative assessment of living cells by measuring their ability to reduce tetrazolium salts. This reduction process is mediated by metabolic enzymes, primarily located in mitochondria, and reflects the functional state of the cell population (Zhang et al., 2020). Because MTT reduction is proportional to viable cell number, the assay enables high-throughput analysis of cytotoxicity, proliferation, and metabolic modulation under various experimental conditions.
Mechanism of Action of MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide)
MTT is a yellow, water-soluble tetrazolium salt. Upon entering intact, metabolically active cells, it is reduced primarily by NADH-dependent mitochondrial oxidoreductases, as well as extra-mitochondrial enzymes, to form insoluble purple formazan crystals (internal reference). The reaction occurs under physiological pH (7.2–7.4) and typically requires 1–4 hours incubation at 37°C. The extent of formazan formation directly correlates with the number of viable cells. The insoluble formazan is then solubilized using DMSO or ethanol, and absorbance is measured spectrophotometrically, usually at 570 nm (APExBIO B7777).
Evidence & Benchmarks
- MTT reduction quantitatively correlates with viable cell number across multiple cell types and experimental models (Zhang et al., 2020).
- MTT is reduced by both mitochondrial and extra-mitochondrial enzymes, ensuring broad applicability across eukaryotic cells (internal review).
- High solubility: ≥41.4 mg/mL in DMSO, ≥18.63 mg/mL in ethanol, ≥2.5 mg/mL in water with sonication (APExBIO B7777).
- Purity of ≥98% in APExBIO’s B7777 product ensures minimal assay background and consistent results (manufacturer certificate).
- MTT assay proven effective in monitoring apoptosis and autophagy modulation in hepatocellular carcinoma models (Zhang et al., 2020).
- Stable at -20°C for at least 12 months; aqueous solutions are recommended for immediate use only (APExBIO B7777).
Applications, Limits & Misconceptions
MTT is widely used in:
- In vitro cell proliferation assays: Quantifies cell growth dynamics in response to drugs, genetic perturbations, or environmental stressors.
- Metabolic activity measurement: Detects bioenergetic changes during differentiation, apoptosis, or metabolic reprogramming.
- Cancer research: Standard in drug screening, cytotoxicity, and apoptosis assays (internal article).
Limits and common misconceptions:
Common Pitfalls or Misconceptions
- Non-viable cells do not reduce MTT: False positives are rare, but dying or metabolically compromised cells may yield weak signals.
- Not suited for all cell types: Cells with extremely low metabolic activity or non-adherent cells may yield inconsistent results.
- Formazan solubility issues: Incomplete solubilization can cause variable absorbance readings; DMSO is preferred as a solvent.
- Interference from colored compounds: Media or test compounds absorbing at 570 nm can confound results; include proper controls (internal troubleshooting guide).
- Not a direct apoptosis assay: MTT reports metabolic activity, which may not always equate to apoptosis without corroborating markers.
Workflow Integration & Parameters
MTT (SKU B7777) from APExBIO offers batch-to-batch reproducibility and is designed for easy incorporation into standard in vitro workflows. For optimal results:
- Dissolve MTT at recommended concentrations: ≥41.4 mg/mL (DMSO), ≥18.63 mg/mL (ethanol), ≥2.5 mg/mL (water, with sonication).
- Incubate cells with 0.5 mg/mL MTT for 1–4 hours at 37°C, 5% CO₂.
- Solubilize formazan crystals with DMSO or ethanol; measure absorbance at 570 nm.
- Store dry powder at -20°C; use freshly prepared solutions for each assay.
This article builds on and extends recent mechanistic reviews (see comparative analysis) by providing new evidence on solubility and application limits, and clarifies troubleshooting not covered in prior thought-leadership content (detailed guide here).
Conclusion & Outlook
MTT remains the benchmark for colorimetric cell viability and metabolic activity assays due to its robust reduction mechanism, high sensitivity, and workflow compatibility. APExBIO’s high-purity B7777 product facilitates reproducible in vitro results across cancer, apoptosis, and metabolic research. Future developments will likely focus on multiplexed assays and integration with high-content screening platforms. For detailed specifications and ordering information, see the MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) product page.